<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29-vaccines-08-00307">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ramanathan</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Kuo</surname>
    <given-names>Y.C.</given-names>
   </name>
   <name>
    <surname>Selling</surname>
    <given-names>B.H.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Sardesai</surname>
    <given-names>N.Y.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Weiner</surname>
    <given-names>D.B.</given-names>
   </name>
  </person-group>
  <article-title>Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes</article-title>
  <source>Vaccine</source>
  <year>2009</year>
  <volume>27</volume>
  <fpage>6444</fpage>
  <lpage>6453</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.06.061</pub-id>
  <pub-id pub-id-type="pmid">19580892</pub-id>
 </element-citation>
</ref>
